Research Guide · Investigative Update

Current Events

Important developments in American healthcare

Broken Promises does not attempt to report every healthcare story. Current Events highlights significant developments that directly relate to the subjects examined throughout this website. Wherever possible, reporting is linked to the underlying primary source.

Last reviewed: November 2, 2026

Discovery is automated — approved government, research, and journalism sources are scanned on a regular schedule — but nothing here is published without editorial review. Each entry is scored for direct relevance to the investigation, checked against its primary source, and written in original language rather than reproduced from the article that broke it.

Filters everything below as you type — no ‘Enter’ needed.

New: Weekly Briefings — a short Monday read on the week's most consequential healthcare developments, linked to the research behind this site.

Current

The Most Significant Recent Developments

Roughly the last several months, selected and scored for direct relevance to the Broken Promises investigation.

November 1, 2026 EVIDENCE UPDATE Insurance & Access

2027 ACA open enrollment opens with a finalized 13% premium increase and a steeper CBO enrollment-decline forecast

Open enrollment for 2027 ACA marketplace coverage began November 1. KFF's enrollment-season rundown finalizes what the September 15 entry on this page covered as proposed rates: average benchmark silver premiums are rising 13% for 2027 (not the 15% insurers initially proposed), the second straight year of double-digit increases, bringing cumulative benchmark premium growth to roughly 42% since 2025. The number of insurers exiting at least one marketplace state for 2027 has grown to 11 (from the nine reported in September), while CBO now projects marketplace enrollment will fall to 13.1 million in 2027 — down from a 2025 peak of 22.4 million — a steeper drop than the agency's earlier projections implied. Separately, CMS has frozen new broker registrations through February 2027 and cut Navigator funding 90%, after canceling roughly 760,000 marketplace enrollments it attributed to unauthorized broker sign-ups.

Why it matters

The September 15 entry on this page described insurers' proposed rates and planned exits for 2027; this is the same story arriving at its real-world starting line, with the actual increase, the actual (larger) list of exits, and a materially worse federal enrollment forecast than the trend data so far had suggested. The broker-fraud crackdown is a separate, double-edged thread — real fraud exists, but cutting the people who help consumers enroll just as the market shrinks and gets more confusing is its own access risk, one this page should probably watch rather than treat as resolved.

October 30, 2026 EVIDENCE UPDATE Healthcare Financialization

Private-equity hospital ownership jumps from 9.5% to 11.9% of private hospitals in three months, driven by one $3.9B deal

The Private Equity Stakeholder Project's fall update to its Hospital Tracker counts 561 U.S. hospitals now under private-equity ownership or operation, up from 447 in its July update — 11.9% of all private hospitals and 33.6% of for-profit hospitals, both sharp jumps in under four months. Most of the increase traces to one transaction: Welsh, Carson, Anderson & Stowe's consortium completed its $3.9 billion acquisition of Select Medical (115 hospitals) on July 1, which combined with its existing Emerus Hospital Partners stake makes WCAS the second-largest PE hospital owner the tracker has identified. The update also documents, for the fuller picture, that at least 144 of the PE-owned hospitals sit under real-estate sale-leaseback arrangements and about a quarter operate as joint ventures with nonprofit systems.

Why it matters

This page's August 25 entry reported private-equity deal volume slowing as states tightened oversight — this update shows ownership share still climbing sharply in the same window, because a handful of large transactions can move the number regardless of overall deal count. The two findings aren't necessarily in tension (fewer, larger deals can still raise concentration), but readers who saw the August item shouldn't assume the PE-hospital story is winding down.

October 29, 2026 DEVELOPMENT Government & Policy

Federal judge partially blocks the Medicaid work-requirement rule's "medically frail" test, but leaves the January 2027 deadline standing

Judge Richard Stearns ruled on cross-motions for summary judgment in Commonwealth of Massachusetts v. Oz, the suit over CMS's Medicaid work-requirement rule that this page has tracked since the July injunction denial and the September "medically frail" lawsuits. He found CMS acted unlawfully by requiring that an exempt condition "significantly impair" someone's ability to meet the work requirement — a narrower test than the five categories Congress wrote into the 2025 law — and permanently enjoined that specific provision, with a six-month stay on frailty determinations while the injunction takes effect. He went the other way on two other challenges, upholding CMS's 12-month lookback period for medical records and its one-self-attestation-per-period limit. The underlying work requirement itself, and its January 1, 2027 start date, were not disturbed.

Why it matters

This is the first real check on the rule rather than a procedural skirmish — the July ruling let the whole rollout proceed, and this one narrows a specific piece of it on the merits. But it's a split decision: the court protected the "medically frail" category from being defined more narrowly than Congress wrote it, while leaving CMS's paperwork-heavy proof requirements (the lookback window, the single-attestation limit) intact, and the core requirement is still set to take effect on schedule. It's a real but partial win for the people the rule has drawn the most criticism over, not a case closed.

October 8, 2026 EVIDENCE UPDATE Patient Harm

JAMA study: the U.S. lost a net 216 hospitals and 24,400 beds from 2010 to 2025; for-profit hospitals closed at three times the nonprofit rate

A JAMA research letter from Harvard T.H. Chan School of Public Health researchers counted 432 acute care hospital closures and 216 openings from 2010 to 2025, a net loss of 216 hospitals and about 24,400 beds, with an estimated 84 million people living in areas affected by a closure. Closure rates were similar in urban (9.1%) and rural (8.3%) areas. For-profit hospitals accounted for about three times as many closures as nonprofits, and closures were more common among safety-net, smaller, and nonteaching hospitals and in states that did not expand Medicaid. Closures rose about 4% a year while openings fell about 3% a year.

Why it matters

This ties together two threads the page already follows, rural hospital closure risk and the shift toward for-profit ownership, and adds that new capacity is being built in urban, for-profit settings that rarely serve many Medicaid patients rather than where need is greatest. It is a short, descriptive research letter, so the ownership and Medicaid-expansion patterns are associations rather than proven causes.

October 6, 2026 EVIDENCE UPDATE Single-Payer & Reform

KFF poll: two-thirds of the public favor a national health plan, the lowest opposition KFF has recorded

KFF's September 2026 Health Tracking Poll, fielded September 16-21, found 66% of the public favor a national health plan, often called Medicare-for-all, and 34% oppose it. Support was 84% among Democrats and 72% among independents; Republicans were 34% in favor and 66% opposed, including 48% strongly opposed. In October 2020, by comparison, 53% favored the idea and 42% opposed it.

Why it matters

This is the strongest single-payer-related public-opinion reading the page has tracked, from a mainstream, nonpartisan pollster. It measures general sympathy for the idea, not support for a specific bill: KFF's own historical work shows the numbers move with question wording and with what respondents are told about taxes and private insurance. The party split also helps explain why majority support has not translated into legislation.

October 6, 2026 EVIDENCE UPDATE Insurance & Access

Urban Institute: more than one in four U.S. adults has medical debt, including 17.6% of adults 65 and older

An Urban Institute brief by Michael Karpman, using the December 2025 Well-Being and Basic Needs Survey of more than 10,000 adults, found 26.6% of adults reported that they or a family member owed medical debt; 15.4% of those had past-due or unpayable bills. Among those with debt, 53.8% owed $1,000 or more, 15.5% owed $5,000 or more, and 35.2% had been contacted by a collection agency. Debt was highest among adults at 100-200% of the poverty level and among Black and Hispanic adults, and 17.6% of adults 65 and older reported it despite near-universal Medicare coverage.

Why it matters

This extends the September 17 Commonwealth Fund finding on privately insured working-age adults to the whole adult population, including Medicare-age adults, and undercuts the idea that having coverage protects people from medical bills. Even in states that restrict medical debt on credit reports, 18.1% of indebted adults reported credit damage, suggesting those laws are not reaching people. The survey was fielded in December 2025, so it predates this year's coverage changes.

October 2, 2026 DEVELOPMENT Government & Policy

A $90 check for Medicare premiums, timed a month before the midterms and funded from a program-operations account

President Trump announced a one-time $90 payment toward Part B premiums for more than 20 million Medicare beneficiaries, funded from the Medicare Improvement Fund - an account Congress created in 2008 for program operations and provider payments, not previously used this way. The payment excludes everyone enrolled in Medicare Advantage, which KFF says is more than half of all beneficiaries, and anyone already receiving premium assistance through Medicaid. It follows a $500 ACA premium rebate announced the prior month and a pledged $5,000 payment to every American adult contingent on Republicans keeping Congress.

Why it matters

KFF's Larry Levitt notes the fund's language is broad enough to give the administration wide discretion - but a one-time $90 check doesn't change the structural premium and cost trends this page tracks elsewhere, and it arrives, like the other payments announced this fall, a few weeks before an election.

October 1, 2026 DEVELOPMENT Insurance & Access

UnitedHealthcare and Humana drop Medicare Advantage plans covering over 1 million seniors for 2027

UnitedHealthcare is discontinuing plans covering about 390,000 members and Humana about 600,000, with non-renewal notices going out October 2; Humana's 2027 footprint will reach just over 80% of U.S. counties, down from 85% this year. CVS Health's Aetna and Centene are also pulling back, per analysts reviewing new government filings, and total Medicare Advantage enrollment is projected to fall about 6% next year, to roughly 34 million. Insurers point to a 2.48% average CMS payment increase for 2027 - an improvement over the 0.09% initially proposed, but still, they say, short of rising medical and drug costs.

Why it matters

Affected seniors can switch plans between October 15 and December 31, or move to original Medicare through February 28, 2027 - but being able to switch isn't the same as finding an equivalent plan, especially for people whose doctors or drug coverage don't carry over. It's the same access disruption this page has tracked on the ACA side (see the September 15 entry), now showing up in Medicare Advantage.

September 30, 2026 POLICY CHANGE Prescription Drugs

CMS finalizes mandatory Part B drug model tying Medicare rebates to what other countries pay

On September 30, CMS finalized the GLOBE Model, a mandatory program that calculates Medicare Part B drug rebates by comparing U.S. prices to international benchmarks from 19 other wealthy countries. Starting January 1, 2027, it applies to high-cost single-source drugs and biologics in oncology, rheumatology, immunology, ophthalmology, and endocrinology in a randomly selected set of areas covering about a quarter of original Medicare beneficiaries, running through March 2032. CMS cites its own data showing Americans pay roughly three to four times what patients in other developed countries pay for brand-name drugs.

Why it matters

This is the administration's "Most Favored Nation" pricing approach extended from Medicaid (see the September 19 entry) into Medicare Part B, through a rebate mechanism rather than a set price. It's the same pattern this page keeps tracking: a government rollout promising major savings, with the actual size of those savings - and who benefits - still untested outside a quarter of the country for the next five years.

September 19, 2026 DEVELOPMENT Prescription Drugs

Leaked drug-pricing contracts show undisclosed terms as all 50 states apply to Medicaid “most-favored-nation” model

On September 18, CMS announced that 40 states and Puerto Rico had signed agreements to join its GENEROUS model, under which participating drugmakers sell to state Medicaid programs at “most-favored-nation” prices benchmarked to other wealthy countries; all 50 states, D.C., and Puerto Rico have applied, with a September 30 deadline to sign. CMS projects $64.3 billion in savings over ten years but has not named the manufacturers or disclosed net prices. A day later, the Washington Post reported on confidential agreements between HHS and Pfizer and Eli Lilly, obtained through Freedom of Information Act litigation, that include tariff protections for the companies, inducements to raise drug prices overseas, and broad confidentiality clauses — with some key terms still unresolved when the deals were announced at the White House.

Why it matters

This is the pattern Before the Counter documents: price concessions announced in public while the terms that decide who actually benefits stay confidential. The administration's savings estimate cannot be independently checked until net prices and contract terms are disclosed.

September 18, 2026 DEVELOPMENT Government & Policy

Medicaid work requirements: physicians and patients file a new suit after states lose their bid to pause the rule

On July 30, a federal judge in Massachusetts declined to pause CMS's Medicaid work-requirement rule while roughly two dozen states pursue their challenge (Massachusetts v. Oz). On September 18, a second suit was filed in federal court in Maryland (Taylor v. Kennedy) by five Medicaid enrollees, the American College of Physicians, the American Academy of Pediatrics, other medical societies, and the City of Columbus. It targets the rule's “medically frail” exemption, arguing CMS added a requirement Congress did not write — that people prove their condition “significantly impairs” their ability to work — effectively applying the work requirement to people the 2025 law exempted. The requirements take effect January 1, 2027.

Why it matters

This is the 2025 reconciliation law's largest coverage-loss provision, with CBO-linked estimates putting millions at risk of losing Medicaid. Whether it takes effect on schedule now turns on these two cases.

September 17, 2026 EVIDENCE UPDATE Healthcare Financialization

HHS Inspector General: Humana and UnitedHealthcare plans overbilled Medicare about $178 million through unsupported diagnoses

Two HHS Office of Inspector General audits reviewed high-risk diagnosis codes — acute stroke, heart attack, sepsis, and others — that Medicare Advantage plans submitted for 2020–2021. For HumanaChoice (contract H5216), 81% of sampled diagnoses were not supported by medical records, an estimated $130.9 million in overpayments; for UnitedHealthcare of Wisconsin (H5253), 73% were unsupported, an estimated $46.9 million. Common errors included coding more severe versions of members' conditions and conditions members had already recovered from. Both insurers disputed OIG's methodology, and neither agreed to refund the overpayments.

Why it matters

Private Medicare plans are paid more for members who look sicker on paper. These audits document that incentive being exploited — one of the core financialization mechanisms this site tracks.

September 17, 2026 EVIDENCE UPDATE Insurance & Access

Commonwealth Fund: one in three privately insured working-age adults is paying off medical debt

A Commonwealth Fund survey of 4,121 continuously insured adults ages 19–64 found that roughly one-third are paying off medical bills or debt over time. Nearly half of those owe $2,000 or more, and 64% trace the debt to hospital care. Among people with debt, 37% depleted their savings, 30% delayed needed care, and 25% had bills sent to collections or credit bureaus. The survey was fielded July–October 2025.

Why it matters

Medical debt is often described as a problem of the uninsured. This survey shows coverage itself doesn't protect people — central to the site's argument that underinsurance is built into the system.

September 15, 2026 DEVELOPMENT Insurance & Access

Nine insurers exit the ACA marketplace for 2027 as the subsidy-expiration risk pool worsens

KFF's tracker confirms nine insurers — including Cigna (leaving 11 states, about 369,000 enrollees), Molina (cutting from 14 states to 6), CareSource, and PacificSource — have filed to leave some or all of their ACA marketplace states for plan year 2027. Insurers cite declining enrollment, rising medical costs, and the expiration of enhanced premium tax credits at the end of 2025, which pushed healthier enrollees out and left a smaller, sicker risk pool behind. It's the second consecutive year of double-digit proposed premium increases (a median 15% for 2027).

Why it matters

This turns the ‘proposed rates’ story into an actual coverage-disruption story: roughly 650,000 marketplace enrollees across a third of states will have to find a new plan for 2027, on top of paying more — the clearest sign yet that the 2025 subsidy expiration is compounding into a second year, not settling out.

September 4, 2026 EVIDENCE UPDATE Patient Harm

KFF: a third of Medicaid-serving rural maternity hospitals are 40+ minutes from the next alternative

KFF's analysis of hospitals providing inpatient maternity care to Medicaid enrollees found that a third of them are rural, with a median drive time to the next in-state alternative of 43 minutes — versus 13 minutes for urban hospitals. In 14 states, losing the nearest rural maternity unit would mean an hour-plus drive. KFF ties the risk of further closures directly to the 2025 reconciliation law's Medicaid provider-payment cuts and work-requirement-driven enrollment losses.

Why it matters

It puts a specific, causal number on a harm this site already tracks in general terms — extending the Commonwealth Fund rural-hospital-crisis entry and the KFF/CBO Medicaid projection entry already on this page by quantifying exactly how much farther Medicaid patients would have to travel for obstetric care as the 2025 law's cuts take hold.

September 1, 2026 DEVELOPMENT Insurance & Access

Bipartisan bill would require a human, not AI, to make medical-necessity claim denials

Reps. Greg Landsman, Kim Schrier, Buddy Carter, and Tom Barrett introduced H.R. 10210, the Doctors Not AI Act of 2026, which would require that any insurance claim denial based on medical necessity be made by a licensed health professional exercising independent clinical judgment — not by AI alone. Insurers could still use AI to help process claims, but would need auditable records showing where AI assisted versus where a human made the final call, and denial letters would have to disclose AI involvement.

Why it matters

It's the first legislative response tracked here to the growing use of AI in claims review — including the ongoing litigation over UnitedHealth's algorithmic denial practices — and it's squarely bipartisan, reflecting how broadly the AI-claims-denial issue has cut across party lines. The bill hasn't passed; this is a marker of where the political fight over automated denials stands, not a settled outcome.

August 31, 2026 EVIDENCE UPDATE Prescription Drugs

Medicare's $50-a-month GLP-1 Bridge program draws over 600,000 enrollees in its first two months

CMS Administrator Dr. Mehmet Oz said more than 600,000 Medicare beneficiaries enrolled in the temporary Medicare GLP-1 Bridge program during its first two months, which lets eligible Part D beneficiaries get weight-loss drugs like Wegovy and Zepbound for a flat $50 monthly copay instead of list prices that can top $1,000 a month. A follow-up report found Walgreens and CVS had each filled over 100,000 prescriptions under the program. The program is a temporary demonstration authorized only through December 31, 2027.

Why it matters

This is a comparatively rare example of a federal program expanding affordable drug access rather than restricting it. The open question is what happens to these 600,000+ people when the demonstration ends in under 15 months with no indication yet of what replaces it — the same kind of cliff-edge design that's caused coverage disruption elsewhere (ACA subsidies, Medicaid redeterminations).

August 30, 2026 DEVELOPMENT Single-Payer & Reform

Pennsylvania state senator circulates memo for a statewide single-payer plan

State Sen. Nikil Saval (D-Philadelphia) circulated a co-sponsorship memo seeking support for a “PA Universal Healthcare Plan” that would create a new state Office of Healthcare covering all residents without copays, deductibles, coinsurance, or caps, funded by a new payroll tax. Saval cited more than $1.8 billion in unpaid medical debt held by Pennsylvania residents. No bill has been formally filed yet.

Why it matters

This is an early-stage legislative move, not a filed bill or a vote — worth tracking rather than treating as a done deal. It follows the same state-level pattern the site has tracked elsewhere (California's CalCare, Washington's Health Trust proposal in One Card, One Cure): single-payer efforts increasingly playing out state by state rather than federally.

August 29, 2026 EVIDENCE UPDATE Government & Policy

The Project 2025 Connection: a written blueprint compared against what actually happened at CDC, NIH, and HHS

Project 2025's Mandate for Leadership proposed narrowing CDC's policy authority, breaking the “NIH monopoly on directing research,” and restructuring HHS — published before the administration took office. A new page on the When Science Became Political book compares that blueprint against the documented 2025–2026 changes at CDC, NIH, and HHS point by point, and is explicit about the difference between correspondence and causation.

Why it matters

This is the rare case where an investigation gets a written blueprint to test against, rather than reconstructing intent after the fact — worth flagging here since it touches the same institutions this site's Science Under Siege coverage tracks.

August 26, 2026 DEVELOPMENT Healthcare Financialization

The Villages Health System agrees to pay $541.5 million over Medicare Advantage upcoding

The Villages Health System LLC, the primary care provider for Florida's Villages retirement community, agreed to pay $541.5 million to resolve False Claims Act allegations that it submitted Medicare Advantage diagnosis codes from 2020–2024 not adequately supported by patients' medical records, inflating risk-adjusted payments from Humana, UnitedHealthcare, and GuideWell/Blue Cross. The company self-disclosed the conduct to HHS's Office of Inspector General in December 2024, earning settlement credit, and the deal was finalized through the company's Chapter 11 bankruptcy proceeding.

Why it matters

This is the same upcoding mechanism already tracked on this page through the HHS-OIG Humana/UnitedHealthcare audit — but roughly three times the dollar size, and resolved as an actual settlement rather than a preliminary audit finding. The self-disclosure detail is a meaningfully different fact pattern than an insurer getting caught by an external audit.

August 25, 2026 EVIDENCE UPDATE Healthcare Financialization

As states tighten oversight, private equity's push into physician practices slows

A PitchBook analysis found private equity-involved healthcare deals declined in the first half of 2026 compared with the same period in 2025, with physician-practice-management deals — the segment where PE has the largest healthcare footprint — on track to fall by half. At least 25 states have proposed or passed laws in recent years adding oversight of healthcare transactions or restricting non-physician control of medical practices; California, Oregon, and Rhode Island each had new transparency requirements take effect in 2026.

Why it matters

Behind the System documents how private-equity ownership has been linked to worse patient outcomes and rising prices. This is the first broad evidence that state-level guardrails — rather than federal action, which the underlying report notes has not yet produced new laws despite congressional investigations — may actually be slowing that consolidation, at least in the segment PE has relied on most.

August 18, 2026 EVIDENCE UPDATE Research & Evidence

Study: four mandatory Medicare value-based payment programs cost hospitals $3 billion a year in added administrative costs

A JAMA Health Forum study comparing 2,820 hospitals under four mandatory Medicare value-based-payment programs against 1,512 non-participating hospitals found administrative-cost increases of $2.06–2.78 million per hospital annually, totaling more than $3 billion nationally. Costs rose fastest at hospitals in markets with heavy Medicare Advantage penetration and in Medicaid-expansion states. Because these programs are designed to be budget-neutral on paper, the authors warn official assessments likely overstate real savings by ignoring this administrative burden, and flag “phantom cost savings” where hospitals cut clinical spending while quietly expanding administrative staff to hit program metrics.

Why it matters

This is a rigorous, peer-reviewed data point on a question central to evaluating any reform proposal: whether claimed savings from a payment model are real or just shifted into unmeasured administrative overhead — directly relevant to how this site's own evidence review weighs administrative-cost claims on both sides of the reform debate.

August 13, 2026 EVIDENCE UPDATE Insurance & Access

KFF analysis: insurers deny 12–18% of prior authorization requests, most appeals never filed

A KFF analysis of prior-authorization metrics found denial rates of 12% for Medicare Advantage, 14% for Medicaid managed care, and 18% for ACA Marketplace plans, with wide variation by insurer. When patients do appeal — which is rare — a large share of denials are overturned: 67% in Medicare Advantage, 47% in Medicaid, 43% in ACA plans.

Why it matters

The gap between the denial rate and the appeal-overturn rate is the story: it suggests a meaningful share of initial denials aren't defensible on the merits, and that the real barrier is how few patients have the time or knowledge to appeal — a direct, current data point for the investigation's argument about insurance-driven delayed and denied care.

August 6, 2026 POLICY CHANGE Prescription Drugs

Five states move PBM reform from proposal to law: Arkansas, California, Iowa, North Carolina, Texas

As of 2026, five states have enacted pharmacy benefit manager reform: Arkansas's Act 624 bars PBMs from owning retail pharmacies; California's SB 41 delinks PBM pay from list price, phases out spread pricing, and caps insulin at $35/month; Iowa, North Carolina, and Texas add rebate pass-through, transparency, and anti-steering rules of their own.

Why it matters

Before the Counter's closing chapter names ending spread pricing and delinking PBM pay from list price as one of six evidence-backed levers — at the time, a recommendation rather than policy. California's SB 41 is now the closest working match to that recommendation as written, anywhere in the country.

Recent Developments

Also Worth Knowing

Selected developments that didn't make the Current list — still verified, still relevant, in brief.

DateHeadlineTopicSource
September 28, 2026 CMS projects Medicare Advantage premiums falling 16.5% for 2027, even as insurers drop plans
Behind the System, Healthcare Reform Overview
Insurance & Access AJMC
August 3, 2026 HRSA revives the 340B drug-rebate pilot; bipartisan bill introduced days later to kill it
Before the Counter, Prescription Drugs research guide
Prescription Drugs Advisory Board
July 24, 2026 Yale preprint projects single-payer would cut national health spending by $1.04 trillion a year
A Case for Single-Payer Healthcare, Bibliography — Hospital & Insurer Consolidation
Research & Evidence Yale School of Public Health
July 14, 2026 FTC settles antitrust case against CVS's Caremark over insulin rebate practices
Before the Counter, Prescription Drugs research guide, Bibliography — PBM section
Prescription Drugs FTC
July 1, 2026 CBO/KFF: projected Medicaid enrollment down 13%, spending down $503 billion since 2025 reconciliation law
Behind the System, Healthcare Reform Overview
Insurance & Access KFF
June 16, 2026 CMS finalizes permanent framework for Medicare drug price negotiation
Before the Counter, Prescription Drugs research guide
Prescription Drugs Federal Register
June 2, 2026 FTC requires divestiture in Ascension Health–AmSurg outpatient surgery deal
Behind the System, Healthcare Financialization guide
Healthcare Financialization FTC
April 21, 2026 California's third single-payer bill dies without a committee hearing
A Case for Single-Payer Healthcare, What Should Replace American Healthcare
Single-Payer & Reform CaloNews
February 9, 2026 Commonwealth Fund: over 400 rural hospitals now at risk of closing
Behind the System, Healthcare Financialization guide
Patient Harm Commonwealth Fund
February 3, 2026 Congress reforms PBM compensation nationally, signed into law
Before the Counter, Prescription Drugs research guide
Prescription Drugs AJMC
November 25, 2025 CMS announces second round of Medicare-negotiated drug prices, effective 2027
Before the Counter, Before the Counter: The 2026 Update, Prescription Drugs research guide
Prescription Drugs AHA News

Archive

Older Developments

DateHeadlineTopicSource
June 27, 2025 Supreme Court upholds no-cost preventive care mandate in Kennedy v. Braidwood Management
Healthcare Reform Overview
Government & Policy Chief Healthcare Executive

Know of a development that belongs here, or think one of these doesn't hold up?